ID PPAL_HUMAN Reviewed; 423 AA. AC P11117; E9PCI1; Q561W5; Q9BTU7; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 03-OCT-2006, sequence version 3. DT 24-JAN-2024, entry version 202. DE RecName: Full=Lysosomal acid phosphatase; DE Short=LAP; DE EC=3.1.3.2; DE Flags: Precursor; GN Name=ACP2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE. RC TISSUE=Placenta; RX PubMed=3191910; DOI=10.1002/j.1460-2075.1988.tb03078.x; RA Pohlmann R., Krentler C., Schmidt B., Schroeder W., Lorkowski G., RA Culley J., Mersmann G., Geier C., Waheed A., Gottschalk S., Grzeschik K.H., RA Hasikik A., von Figura K.; RT "Human lysosomal acid phosphatase: cloning, expression and chromosomal RT assignment."; RL EMBO J. 7:2343-2350(1988). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Leukocyte; RX PubMed=2776754; DOI=10.1111/j.1432-1033.1989.tb21090.x; RA Geier C., von Figura K., Pohlmann R.; RT "Structure of the human lysosomal acid phosphatase gene."; RL Eur. J. Biochem. 183:611-616(1989). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLN-29. RC TISSUE=Thalamus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16554811; DOI=10.1038/nature04632; RA Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., RA Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., RA Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., RA Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., RA Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., RA Hattori M., Rogers J., Lander E.S., Sakaki Y.; RT "Human chromosome 11 DNA sequence and analysis including novel gene RT identification."; RL Nature 440:497-500(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-29. RC TISSUE=Kidney, and Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PARTIAL PROTEIN SEQUENCE, PROTEOLYTIC PROCESSING, AND SUBCELLULAR LOCATION. RX PubMed=2684640; DOI=10.1002/j.1460-2075.1989.tb08480.x; RA Gottschalk S., Waheed A., Schmidt B., Laidler P., von Figura K.; RT "Sequential processing of lysosomal acid phosphatase by a cytoplasmic thiol RT proteinase and a lysosomal aspartyl proteinase."; RL EMBO J. 8:3215-3219(1989). RN [7] RP DISEASE. RX PubMed=5410815; DOI=10.1056/nejm197002052820604; RA Nadler H.L., Egan T.J.; RT "Deficiency of lysosomal acid phosphatase. A new familial metabolic RT disorder."; RL N. Engl. J. Med. 282:302-307(1970). RN [8] RP SUBCELLULAR LOCATION, GLYCOSYLATION, MEMBRANE TOPOLOGY, AND PROTEOLYTIC RP PROCESSING. RX PubMed=3056714; DOI=10.1002/j.1460-2075.1988.tb03079.x; RA Waheed A., Gottschalk S., Hille A., Krentler C., Pohlmann R., Braulke T., RA Hauser H., Geuze H., von Figura K.; RT "Human lysosomal acid phosphatase is transported as a transmembrane protein RT to lysosomes in transfected baby hamster kidney cells."; RL EMBO J. 7:2351-2358(1988). RN [9] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-92; ASN-133; ASN-167; ASN-177; RP ASN-267 AND ASN-331. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). CC -!- CATALYTIC ACTIVITY: CC Reaction=a phosphate monoester + H2O = an alcohol + phosphate; CC Xref=Rhea:RHEA:15017, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:67140; EC=3.1.3.2; CC -!- INTERACTION: CC P11117; Q86V38: ATN1; NbExp=3; IntAct=EBI-2907070, EBI-11954292; CC P11117; Q9UQC2: GAB2; NbExp=3; IntAct=EBI-2907070, EBI-975200; CC P11117; Q92876: KLK6; NbExp=3; IntAct=EBI-2907070, EBI-2432309; CC P11117; Q13153: PAK1; NbExp=3; IntAct=EBI-2907070, EBI-1307; CC -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:2684640, CC ECO:0000269|PubMed:3056714}; Single-pass membrane protein CC {ECO:0000255}; Lumenal side {ECO:0000305|PubMed:2684640, CC ECO:0000305|PubMed:3056714}. Lysosome lumen. Note=The soluble form CC arises by proteolytic processing of the membrane-bound form. CC {ECO:0000269|PubMed:2684640, ECO:0000269|PubMed:3056714}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P11117-1; Sequence=Displayed; CC Name=2; CC IsoId=P11117-2; Sequence=VSP_045629, VSP_045630; CC -!- PTM: The membrane-bound form is converted to the soluble form by CC sequential proteolytic processing. First, the C-terminal cytoplasmic CC tail is removed. Cleavage by a lysosomal protease releases the soluble CC form in the lysosome lumen. {ECO:0000269|PubMed:2684640, CC ECO:0000269|PubMed:3056714}. CC -!- PTM: N-glycosylated. The intermediates formed during enzymatic CC deglycosylation suggest that all eight predicted N-glycosylation sites CC are used. {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:3056714}. CC -!- DISEASE: Note=Lysosomal acid phosphatase has been shown to be deficient CC in cultured fibroblasts from patients manifesting intermittent CC vomiting, hypotonia, lethargy, opisthotonos, terminal bleeding and CC death in early infancy. {ECO:0000269|PubMed:5410815}. CC -!- SIMILARITY: Belongs to the histidine acid phosphatase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X12548; CAA31064.1; -; mRNA. DR EMBL; X15525; CAA33542.1; -; Genomic_DNA. DR EMBL; X15526; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15527; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15528; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15529; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15530; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15531; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15532; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15533; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15534; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; X15535; CAA33542.1; JOINED; Genomic_DNA. DR EMBL; DA382854; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AC018410; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC003160; AAH03160.1; -; mRNA. DR EMBL; BC093010; AAH93010.1; -; mRNA. DR CCDS; CCDS7928.1; -. [P11117-1] DR PIR; S06167; S06167. DR RefSeq; NP_001289418.1; NM_001302489.1. DR RefSeq; NP_001289419.1; NM_001302490.1. DR RefSeq; NP_001289420.1; NM_001302491.1. DR RefSeq; NP_001289421.1; NM_001302492.1. DR RefSeq; NP_001601.1; NM_001610.3. [P11117-1] DR AlphaFoldDB; P11117; -. DR BMRB; P11117; -. DR SMR; P11117; -. DR BioGRID; 106569; 133. DR ELM; P11117; -. DR IntAct; P11117; 41. DR DEPOD; ACP2; -. DR GlyConnect; 1476; 13 N-Linked glycans (5 sites), 1 O-Linked glycan (1 site). DR GlyCosmos; P11117; 9 sites, 13 glycans. DR GlyGen; P11117; 13 sites, 19 N-linked glycans (6 sites), 2 O-linked glycans (5 sites). DR iPTMnet; P11117; -. DR PhosphoSitePlus; P11117; -. DR SwissPalm; P11117; -. DR BioMuta; ACP2; -. DR DMDM; 115502439; -. DR CPTAC; CPTAC-1309; -. DR EPD; P11117; -. DR jPOST; P11117; -. DR MassIVE; P11117; -. DR MaxQB; P11117; -. DR PaxDb; 9606-ENSP00000256997; -. DR PeptideAtlas; P11117; -. DR ProteomicsDB; 19451; -. DR ProteomicsDB; 52693; -. [P11117-1] DR Pumba; P11117; -. DR TopDownProteomics; P11117-1; -. [P11117-1] DR Antibodypedia; 26620; 120 antibodies from 24 providers. DR DNASU; 53; -. DR Ensembl; ENST00000256997.9; ENSP00000256997.3; ENSG00000134575.13. [P11117-1] DR Ensembl; ENST00000672073.1; ENSP00000500291.1; ENSG00000134575.13. [P11117-1] DR GeneID; 53; -. DR KEGG; hsa:53; -. DR MANE-Select; ENST00000672073.1; ENSP00000500291.1; NM_001610.4; NP_001601.1. DR UCSC; uc001nei.3; human. [P11117-1] DR AGR; HGNC:123; -. DR CTD; 53; -. DR DisGeNET; 53; -. DR GeneCards; ACP2; -. DR HGNC; HGNC:123; ACP2. DR HPA; ENSG00000134575; Low tissue specificity. DR MalaCards; ACP2; -. DR MIM; 171650; gene. DR neXtProt; NX_P11117; -. DR NIAGADS; ENSG00000134575; -. DR OpenTargets; ENSG00000134575; -. DR PharmGKB; PA24447; -. DR VEuPathDB; HostDB:ENSG00000134575; -. DR eggNOG; KOG3720; Eukaryota. DR GeneTree; ENSGT00940000158446; -. DR InParanoid; P11117; -. DR OMA; QESDWPQ; -. DR OrthoDB; 5489935at2759; -. DR PhylomeDB; P11117; -. DR TreeFam; TF312893; -. DR PathwayCommons; P11117; -. DR SignaLink; P11117; -. DR BioGRID-ORCS; 53; 12 hits in 1168 CRISPR screens. DR ChiTaRS; ACP2; human. DR GeneWiki; ACP2; -. DR GenomeRNAi; 53; -. DR Pharos; P11117; Tbio. DR PRO; PR:P11117; -. DR Proteomes; UP000005640; Chromosome 11. DR RNAct; P11117; Protein. DR Bgee; ENSG00000134575; Expressed in right lobe of liver and 197 other cell types or tissues. DR ExpressionAtlas; P11117; baseline and differential. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0043202; C:lysosomal lumen; IEA:UniProtKB-SubCell. DR GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005764; C:lysosome; IDA:MGI. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0003993; F:acid phosphatase activity; IBA:GO_Central. DR GO; GO:0016311; P:dephosphorylation; IBA:GO_Central. DR GO; GO:0007040; P:lysosome organization; IBA:GO_Central. DR CDD; cd07061; HP_HAP_like; 1. DR Gene3D; 3.40.50.1240; Phosphoglycerate mutase-like; 1. DR InterPro; IPR033379; Acid_Pase_AS. DR InterPro; IPR000560; His_Pase_clade-2. DR InterPro; IPR029033; His_PPase_superfam. DR PANTHER; PTHR11567; ACID PHOSPHATASE-RELATED; 1. DR PANTHER; PTHR11567:SF180; LYSOSOMAL ACID PHOSPHATASE; 1. DR Pfam; PF00328; His_Phos_2; 1. DR SUPFAM; SSF53254; Phosphoglycerate mutase-like; 1. DR PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1. DR PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1. DR Genevisible; P11117; HS. PE 1: Evidence at protein level; KW Alternative splicing; Direct protein sequencing; Disulfide bond; KW Glycoprotein; Hydrolase; Lysosome; Membrane; Reference proteome; Signal; KW Transmembrane; Transmembrane helix. FT SIGNAL 1..30 FT CHAIN 31..423 FT /note="Lysosomal acid phosphatase" FT /id="PRO_0000023960" FT TOPO_DOM 31..380 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 381..401 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 402..423 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT ACT_SITE 42 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT ACT_SITE 287 FT /note="Proton donor" FT /evidence="ECO:0000250" FT CARBOHYD 92 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT CARBOHYD 133 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT CARBOHYD 167 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT CARBOHYD 177 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT CARBOHYD 191 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000305|PubMed:3056714" FT CARBOHYD 267 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT CARBOHYD 322 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000305|PubMed:3056714" FT CARBOHYD 331 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT DISULFID 159..370 FT /evidence="ECO:0000250" FT DISULFID 212..310 FT /evidence="ECO:0000250" FT DISULFID 345..349 FT /evidence="ECO:0000250" FT VAR_SEQ 151..160 FT /note="LLKFPLGPCP -> VRVASPSLGW (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_045629" FT VAR_SEQ 161..423 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_045630" FT VARIANT 29 FT /note="R -> Q (in dbSNP:rs2167079)" FT /evidence="ECO:0000269|PubMed:14702039, FT ECO:0000269|PubMed:15489334" FT /id="VAR_027801" FT VARIANT 320 FT /note="S -> F (in dbSNP:rs34425282)" FT /id="VAR_034394" FT VARIANT 402 FT /note="V -> I (in dbSNP:rs4647764)" FT /id="VAR_050519" SQ SEQUENCE 423 AA; 48344 MW; 3431A30B83A1E2B4 CRC64; MAGKRSGWSR AALLQLLLGV NLVVMPPTRA RSLRFVTLLY RHGDRSPVKT YPKDPYQEEE WPQGFGQLTK EGMLQHWELG QALRQRYHGF LNTSYHRQEV YVRSTDFDRT LMSAEANLAG LFPPNGMQRF NPNISWQPIP VHTVPITEDR LLKFPLGPCP RYEQLQNETR QTPEYQNESS RNAQFLDMVA NETGLTDLTL ETVWNVYDTL FCEQTHGLRL PPWASPQTMQ RLSRLKDFSF RFLFGIYQQA EKARLQGGVL LAQIRKNLTL MATTSQLPKL LVYSAHDTTL VALQMALDVY NGEQAPYASC HIFELYQEDS GNFSVEMYFR NESDKAPWPL SLPGCPHRCP LQDFLRLTEP VVPKDWQQEC QLASGPADTE VIVALAVCGS ILFLLIVLLL TVLFRMQAQP PGYRHVADGE DHA //